ESR1 and breast cancer: First the expression levels of ERα mRNA and miR-342 were assessed in the breast cancer cell lines and the results showed that they were greatly increased in the ERα-positive cells (MCF-7) compared with those in the ERα-negative cells (SKBR-3 and MB-231; P<0.05; Fig. 1A–C).